Thyrocare Promoter Docon Sells 9.9% Stake

Key Quantitative Figures

• Number of shares sold: 1,57,69,696 equity shares
• Percentage of total paid-up equity share capital: 9.90%
• Pre-transaction promoter shareholding: 60.92%
• Post-transaction promoter shareholding: 51.02%

Parties Involved

• Selling entity: Docon Technologies Private Limited (Promoter)
• Disclosure signed by: Brijesh Kumar, Company Secretary and Compliance Officer
• Recipients: National Stock Exchange of India Limited and BSE Limited

Capital Structure Impact

Following the transaction, Docon Technologies Private Limited continues to be a Promoter and holding company of Thyrocare Technologies Limited. The promoter shareholding has reduced by 9.90 percentage points from 60.92% to 51.02% of the total paid-up equity share capital.